The pathophysiological pathways by which MetS elicits inflammation and cardiac fibrogenesis are complex and multifactorial, with contributions from oxidative stress, insulin resistance, and pro-inflammatory cytokines. The gene discussed is INS; the disease is metabolic syndrome.